Of sound mind pete. I don't think I've lost 1 nights sleep on the direction of $IPIX. As Citrati even mentioned earlier, if one knows how to trade theyve made good money here on the various moves as well as the big one. My cost basis is under the $ and i do have more shares now than I did back when this was in the .20's.
Not without risk, sure there's risk. Brilacidin has taken MUCH of that risk off the table. The prospects of kevetrin are only getting more impressive. And I'm with some others on the potential of prurisol having a 60/40 chance, maybe a bit better. Thoughts on partnering before topline data sets are out, well, maybe. Plans can be made but I'd think full data would be published first. Doesn't need to be though. Especially with what we know of brilacidin.
Some excellent posts today longs. Steady as she goes.